| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/10/2011 | US20110033393 Hydrazone Compounds and Their Use |
| 02/10/2011 | CA2770195A1 Aminopyrazole derivative |
| 02/10/2011 | CA2770156A1 Novel bicyclic urea compounds |
| 02/10/2011 | CA2770155A1 Novel azaheterocyclic compounds |
| 02/10/2011 | CA2769245A1 Mesoionic pesticides |
| 02/10/2011 | CA2768632A1 Process for the manufacture of pharmaceutically active compounds |
| 02/10/2011 | CA2763956A1 Metabotropic glutamate receptor modulators |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2280981A1 Bridged heterocycles as hiv integrase inhibitors |
| 02/09/2011 | EP2280972A1 Doubly reduced perylene-diimides and supramolecular polymers derived from perylene-diimides |
| 02/09/2011 | EP2280971A1 N,n'-bis(fluorophenylalkyl)-substituted perylene-3,4:9,10-tetracarboximides, and the preparation and use thereof |
| 02/09/2011 | EP2280970A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors |
| 02/09/2011 | EP2280969A1 Pyrimidinyl pyridone inhibitors of jnk. |
| 02/09/2011 | EP2280968A2 Pyrido [3, 4-b]indoles and methods of use |
| 02/09/2011 | EP2280967A2 Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity |
| 02/09/2011 | EP2280959A1 Novel compounds |
| 02/09/2011 | EP2280954A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2 |
| 02/09/2011 | EP2280953A1 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/09/2011 | EP2280943A1 New substituted spiroýcycloalkyl-1,3'-indol¨-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors. |
| 02/09/2011 | EP2280766A1 Carboxamide compounds and their use as chemokine receptor agonists |
| 02/09/2011 | EP2280706A1 Lipoprotein lipase-activating compositions comprising benzene derivates |
| 02/09/2011 | EP2280705A1 Novel compounds |
| 02/09/2011 | EP1931656B1 Novel drugs for dementia |
| 02/09/2011 | EP1689390B1 Methods and reagents for the treatment of inflammatory disorders |
| 02/09/2011 | CN101970438A Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 02/09/2011 | CN101970437A Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/09/2011 | CN101970436A Azaindole compounds for treatment of central nervous system disorders |
| 02/09/2011 | CN101970435A Pyrrolopyrimidines and pyrrolopyridines |
| 02/09/2011 | CN101970434A Process for the preparation of 2,3,4,9-tetrahydro-1h-beta-carbolin-3-carboxylic acid esters |
| 02/09/2011 | CN101970426A Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer |
| 02/09/2011 | CN101967147A S-triazacoronene compound and synthesis method and application thereof |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101967145A Method for preparing antithrombotic medicament apixaban |
| 02/09/2011 | CN101967144A Phenanthroline derivative and preparation method and application thereof |
| 02/08/2011 | US7884207 such as 4-[(4-Amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl]tetrahydro-2H-pyran-4-ol, used as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases |
| 02/08/2011 | US7884204 Phenylalanine derivatives |
| 02/08/2011 | US7884120 microbiocides such as 2-(2-methyl-1H-indol-3-yl)-3a,11b-dihydro-1H-phenanthro[9,10-d]imidazole; bactericides; fungicides |
| 02/08/2011 | US7884112 Pyrrolopyridine-2-carboxylic acid hydrazides |
| 02/08/2011 | US7884109 immunosuppressants such as 2-(6-Fluoro-1H-benzo[d]imidazol-1-yl)-9-((1R,4R)-4-hydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)-7H-purin-8(9H)-one, used for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 02/08/2011 | US7884080 Administering an azetidinone compound for treating a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease; T-type calcium channel blocking agent, an antagonist of TRPV1, an agonist of TRPV1, of GPR119, antagonist of NPCL1 |
| 02/08/2011 | CA2610888C Inhibitors of akt activity |
| 02/08/2011 | CA2605899C Triazole derivatives as vasopressin antagonists |
| 02/08/2011 | CA2586179C Sulfonyl benzimidazole derivatives |
| 02/08/2011 | CA2553785C Compounds and compositions as protein kinase inhibitors |
| 02/08/2011 | CA2480940C Non-steroidal progesterone receptor modulators |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
| 02/03/2011 | WO2011014795A2 Compounds and compositions as syk kinase inhibitors |
| 02/03/2011 | WO2011014681A1 Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS |
| 02/03/2011 | WO2011014535A1 COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION |
| 02/03/2011 | WO2011014515A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors |
| 02/03/2011 | WO2011014462A1 Fused heterocyclic compounds as ion channel modulators |
| 02/03/2011 | WO2011014098A1 Hydrogenated pyrido[4,3-b]indole derivatives, pharmaceutical composition and methods for the production and use thereof |
| 02/03/2011 | WO2011014039A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/03/2011 | WO2011013752A1 Pharmaceutical composition containing fused hetero-ring derivative |
| 02/03/2011 | WO2011013002A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2 |
| 02/03/2011 | WO2011012622A1 Benzoxazinone derivatives for the treatment of glytl mediated disorders |
| 02/03/2011 | WO2011012600A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines |
| 02/03/2011 | WO2011012538A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals |
| 02/03/2011 | WO2010124042A3 Modulators of 5-ht receptors and methods of use thereof |
| 02/03/2011 | WO2010115491A3 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 02/03/2011 | WO2010025906A3 Hybrid antimicrobial compounds and their use |
| 02/03/2011 | US20110028720 New Coupling Agents for Peptide Synthesis |
| 02/03/2011 | US20110028717 Azaindole derivative having pgd2 receptor antagonistic activity |
| 02/03/2011 | US20110028711 Unsaturated Steroid Compounds |
| 02/03/2011 | US20110028512 Bis-heterocyclic imidazolyl compounds |
| 02/03/2011 | US20110028511 Process for the manufacture of pharmaceutically active compounds |
| 02/03/2011 | US20110028509 Sulfonamides |
| 02/03/2011 | US20110028483 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
| 02/03/2011 | US20110028452 PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS |
| 02/03/2011 | US20110028450 Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines |
| 02/03/2011 | US20110028447 Indazole derivatives |
| 02/03/2011 | US20110028445 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 02/03/2011 | US20110028310 Catalysts and methods for catalytic oxidation |
| 02/03/2011 | US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings |
| 02/03/2011 | US20110027227 Antiviral drugs for treatment of arenavirus infection |
| 02/03/2011 | US20110027226 Indolopyridines as inhibitors of the kinesin spindle protein (eg5) |
| 02/03/2011 | CA2774715A1 Fused heterocyclic compounds as ion channel modulators |
| 02/03/2011 | CA2769298A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2 |
| 02/03/2011 | CA2769056A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines |
| 02/03/2011 | CA2766535A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals |
| 02/03/2011 | CA2766515A1 Compounds for the reduction of .beta.-amyloid production |
| 02/02/2011 | EP2280011A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2 |
| 02/02/2011 | EP2280008A2 Heterocyclic-substituted piperidines as ORL-1 ligands |
| 02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
| 02/02/2011 | EP2279737A1 Heterocyclic compounds that are active as beta lactamase inhibitors |
| 02/02/2011 | EP2279187A1 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/02/2011 | EP2279186A1 CONVERSION OF TRYPTOPHAN INTO ß-CARBOLINE DERIVATIVES |
| 02/02/2011 | EP2279177A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/02/2011 | EP2278973A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors |
| 02/02/2011 | EP2278969A2 Inhibitors of janus kinases |
| 02/02/2011 | EP2032577B1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 02/02/2011 | EP1869042B1 Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities |
| 02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
| 02/02/2011 | CN1942191B Pharmaceutical composition comprising a salt of mirtazapine |
| 02/02/2011 | CN1838953B 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 02/02/2011 | CN101965347A Pyrazolopyridines as kinase inhibitors |
| 02/02/2011 | CN101965343A 2-aza-bicyclo[2.2.1]heptane derivatives |
| 02/02/2011 | CN101962382A Symmetric nickel naphthotriazine complex and application thereof |